ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,445,116 | -27.1% | 90,998 | -3.3% | 0.02% | -22.6% |
Q2 2023 | $3,355,035 | +36.0% | 94,084 | -3.1% | 0.03% | +29.2% |
Q1 2023 | $2,467,178 | +85387.8% | 97,133 | +36.5% | 0.02% | -45.5% |
Q4 2022 | $2,886 | -99.9% | 71,161 | -6.5% | 0.04% | +10.0% |
Q3 2022 | $2,516,000 | -6.4% | 76,127 | -0.3% | 0.04% | -7.0% |
Q2 2022 | $2,688,000 | -21.8% | 76,349 | +2.1% | 0.04% | -8.5% |
Q1 2022 | $3,438,000 | -31.0% | 74,766 | -0.5% | 0.05% | -23.0% |
Q4 2021 | $4,984,000 | +3.5% | 75,167 | -2.5% | 0.06% | +3.4% |
Q3 2021 | $4,815,000 | -25.0% | 77,124 | -0.6% | 0.06% | -21.3% |
Q2 2021 | $6,424,000 | +24.9% | 77,567 | +0.0% | 0.08% | +17.2% |
Q1 2021 | $5,142,000 | -21.4% | 77,542 | -9.1% | 0.06% | -22.0% |
Q4 2020 | $6,545,000 | +59.1% | 85,303 | -10.7% | 0.08% | +49.1% |
Q3 2020 | $4,115,000 | +18.5% | 95,563 | +18.8% | 0.06% | 0.0% |
Q2 2020 | $3,473,000 | +41.6% | 80,409 | -5.7% | 0.06% | +22.2% |
Q1 2020 | $2,453,000 | -43.5% | 85,254 | +24.5% | 0.04% | -31.8% |
Q4 2019 | $4,343,000 | +137.6% | 68,473 | +5.6% | 0.07% | +127.6% |
Q3 2019 | $1,828,000 | +120.0% | 64,865 | +106.9% | 0.03% | +123.1% |
Q2 2019 | $831,000 | – | 31,348 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |